x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- dyslipidemiaRemove dyslipidemia filter
- low density lipoproteinRemove low density lipoprotein filter
Author
- Abumrad, Nada A1
- Allum, Fiona1
- Arnett, Donna K1
- Aslibekyan, Stella1
- Basu, Arpita1
- Borecki, Ingrid B1
- Deloukas, Panos1
- Duan, Yanan1
- Grundberg, Elin1
- Hedman, Åsa K1
- Hopkins, Paul N1
- Jenkins, Alicia J1
- Klein, Richard L1
- Kraja, Aldi T1
- Lopes-Virella, Maria F1
- Love-Gregory, Latisha1
- Lyons, Timothy J1
- McCarthy, Mark I1
- Ordovas, Jose M1
- Stoner, Julie A1
- Zhang, Ying1
JLR Patient-Oriented and Epidemiological Research
2 Results
- Patient-Oriented and Epidemiological ResearchOpen Access
Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36
Journal of Lipid ResearchVol. 57Issue 12p2176–2184Published online: October 11, 2016- Latisha Love-Gregory
- Aldi T. Kraja
- Fiona Allum
- Stella Aslibekyan
- Åsa K. Hedman
- Yanan Duan
- and others
Cited in Scopus: 23Cluster of differentiation 36 (CD36) variants influence fasting lipids and risk of metabolic syndrome, but their impact on postprandial lipids, an independent risk factor for cardiovascular disease, is unclear. We determined the effects of SNPs within a ∼410 kb region encompassing CD36 and its proximal and distal promoters on chylomicron (CM) remnants and LDL particles at fasting and at 3.5 and 6 h following a high-fat meal (Genetics of Lipid Lowering Drugs and Diet Network study, n = 1,117). Five promoter variants associated with CMs, four with delayed TG clearance and five with LDL particle number. - Patient-Oriented and Epidemiological ResearchOpen Access
Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes
Journal of Lipid ResearchVol. 57Issue 2p310–317Published online: December 9, 2015- Ying Zhang
- Alicia J. Jenkins
- Arpita Basu
- Julie A. Stoner
- Maria F. Lopes-Virella
- Richard L. Klein
- and others
Cited in Scopus: 12Our objective is to define differences in circulating lipoprotein subclasses between intensive versus conventional management of type 1 diabetes during the randomization phase of the Diabetes Control and Complications Trial (DCCT). NMR-determined lipoprotein subclass profiles (NMR-LSPs), which estimate molar subclass concentrations and mean particle diameters, were determined in 1,294 DCCT subjects after a median of 5 years (interquartile range: 4–6 years) of randomization to intensive or conventional diabetes management.